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A B S T R A C T
Psychiatric comorbidity is extremely common. One of the most common and difﬁcult to manage
comorbid conditions is the co-occurrence of bipolar disorder (BD) and obsessive compulsive disorder
(OCD). We updated our recent systematic review searching the electronic databases MEDLINE, Embase,
and PsycINFO to investigate course of illness in BD–OCD patients. We identiﬁed a total of 13 relevant
papers which found that the majority of comorbid OCD cases appeared to be related to mood episodes.
OC symptoms in comorbid patients appeared more often during depressive episodes, and comorbid BD
and OCD cycled together, with OC symptoms often remitting during manic/hypomanic episodes.
 2016 Elsevier B.V. All rights reserved.
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A diagnosis can be considered valid when one can differentiate
it from other diagnoses. In a classic 1970 paper Robins and Guze
described criteria to deﬁne the validity of a diagnostic construct of
interest based on the availability of data on phenomenology,
course of illness, heredity, biological markers, and treatment
response (Robins and Guze, 1970).
Psychiatric comorbidity is extremely common in bipolar
disorder (BD). More than half of BD patients have an additional
diagnosis, one of the most difﬁcult to manage being obsessive–
compulsive disorder (OCD). In our recent meta-analysis, the pooled
prevalence of OCD in BD was 17.0% (95% CI 12.7 to 22.4%), which
was comparable to the results reported by the pooled prevalence of
BD in OCD (18.35%, 95% CI 13.2 to 24.8%) (Amerio et al., 2015).
Although recent studies have investigated the co-occurrence of
anxiety disorders and BD, the topic is insufﬁciently studied and the* Corresponding author at: Department of Clinical and Experimental Medicine,
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1876-2018/ 2016 Elsevier B.V. All rights reserved.relationship between BD and OCD remains unclear (Amerio et al.,
2014a; Tonna et al., 2015). What remains unclear is whether this
high comorbidity represents the frequent occurrence of two
independent diseases, or whether it represents the occurrence of
symptoms of one kind (e.g., OCD symptoms) in a different disease
(i.e., BD).
In agreement with Kraepelin’s thought a psychiatric diagnosis is
best established by its longitudinal course of illness, we updated
our recent systematic review to investigate speciﬁcally the course
of illness in BD–OCD patients.
2. Updated systematic review
Studies were identiﬁed by searching the electronic databases
MEDLINE, Embase, and PsycINFO. We combined the search strategy
of free text terms and exploded MESH headings for the topics of
bipolar disorder, obsessive–compulsive disorder and treatment
combined as following: (((((((((‘‘Bipolar Disorder’’[Mesh]) OR
Bipolar disorder) OR BD) OR Bipolar) OR Manic depressive disorder)
OR Manic depressive) OR Manic)) AND ((((‘‘Obsessive-Compulsive
Disorder’’[Mesh]) OR OCD) OR Obsessive-compulsive) OR Obses-
sive-compulsive disorder)). Studies published in English through
November 15th, 2015 were included.
Thirteen studies were selected (Table 1). Higher rates of
episodic OCD were reported in BD–OCD patients as compared to
Table 1
Studies that met inclusion/exclusion criteria for systematic review.
References Study design Country Study population Diagnosis
assessment
Results Quality *
Goes et al. (2012)1 Cross-
sectional
study
USA BD (n = 1416, mean
age = 42.0), ﬁrst-degree
relatives with BD (n = 850)
DIGS; DSM-IV Higher number of depressive episodes in OCD–BD
patients vs. non-OCD–BD patients (19.7 vs. 10.3).
23/31
Issler et al. (2005)2 Case control
study
Brazil OCD–BD (n = 15, mean
age = 38.9  10.7)
SCID; DSM-IV Higher rate of chronic course of OCD in OCD–BD patients
vs. non-OCD–BD patients (86.7% vs. 13.3%)b
14/31
Issler et al. (2010)3 Case control
study
Brazil BD (n = 30, mean age:
BD = 41.8  10.5,
OCD–BD = 38.9  10.7)
SCID; DSM-IV Higher number of depressive episodes in OCD-BD
patients vs. non-OCD–BD patients (8.9  4.2 vs. 4.1  2.7).
Higher rate of chronic course of BD in OCD–BD patients vs.
non-OCD–BD patients (66.7% vs. 20%)c
17/31
Koyuncu et al. (2010)4 Case control
study
Turkey BD (n = 214, mean age:
BD = 34.8  10.3, OCD–
BD = 36.2  15.9)
SCID; DSM-IV Higher rate of chronic course of BD in OCD-BD patients
vs. non-OCD-BD patients (17.1% vs. 0.0%)c
20/31
Mahasuar et al. (2011)5 Case control
study
India OCD (n = 91, mean age:
OCD = 29.36  8.31,
BD–OCD = 28.39  7.10)
SCID; DSM-IV Episodic course overrepresented in BD–OCD patients vs.
patients without comorbidity (53% vs. 12%); higher rates
of continuous (40% vs. 35%) or subclinical (32% vs. 6%)
course in non-BD–OCD patients vs.
BD–OCD patientsa,b
19/31
Ozdemiroglu
et al. (2015)6
Case control
study
Turkey BD (n = 48, mean
age = 42.3  12.4), OCD
(n = 61, mean
age = 37.7  12.9), BD–OCD
(n = 32, mean age = 36.2  12)
SCID; DSM-IV A more episodic course of OCD, higher rates of rapid
cycling, and the seasonality were found in BD–OCD
patients. Depressive bipolar patients had a more severe
OCD compared to euthymic patientsa
23/31
Perugi et al. (1997)7 Case control
study
Italy OCD (n = 315, mean age:
BD–OCD = 32.8  12.2,
OCD = 32.5  12.6)
NS; DSM-III-R BD–OCD pt. were more inclined towards an episodic
course of OCD symptoms vs. non-BD–OCD patients
(42.6% vs. 26.9%)a
22/31
Perugi et al. (1998)8 Case control
study
Italy OCD (n = 135, mean
age = 38.4  13.3)
NS; DSM-III-R Statistically non-signiﬁcant trends of higher rate of
episodic OCD course in OCD patients with comorbid BD-
II vs. patients without comorbiditya
21/31
Perugi et al. (2002)9 Case control
study
Italy OCD-MDE (n = 68, mean
age = 34.2  12.5); BD–OCD
(n = 38, mean
age = 35.9  12.2)
SCID; DSM-IV Higher rate of episodic course of OCD in BD–OCD
patients vs. non-BD–OCD patients (52.6% vs. 16.7%)a
20/31
Strakowski
et al. (1998)10
Cross-
sectional
study
USA BD, manic or mixed with
psychosis (n = 77, mean
age = 25  6)
SCID; DSM-III-R BD and OCD cycled together in 44% of BD–OCD patients
followed for 12 months after a ﬁrst hospitalization
22/31
Tukel et al. (2006)11 Case control
study
Turkey OCD (n = 115, age > 18) SCID; DSM-IV Higher number of BD–OCD patients with an episodic
course of OCD vs. non-BD–OCD patients (42.3% vs.
10.9%)a
21/31
Tukel et al. (2007)12 Case control
study
Turkey OCD (n = 128, mean
age = 29.3  10.8)
SCID; DSM-IV Higher frequency of BD in patients with episodic OCD
than in patients with chronic OCD (20.8% vs. 3.8%)a
21/31
Zutshi et al. (2007)13 Case control
study
India OCD (n = 106, mean age:
BD–OCD = 27.93  6.71,
OCD = 26.47  7.38)
SCID; DSM-IV Higher rate of episodic course of OCD in BD–OCD
patients vs. non-BD–OCD patients (75% vs. 3%); higher
rate of chronic course of OCD in non-BD–OCD patients vs.
patients with comorbidity (97% vs. 14%). Most BD–OCD
patients (78%) either had OCD conﬁned exclusively to
depressive episodes or reported worsening of OCD
during depression. Improvement in OC symptoms was
noted in 64% patients during manic/hypomanic
episodesa,b
20/31
BD: bipolar disorder; OCD: obsessive–compulsive disorder; DSM: Diagnostic and Statistical Manual of Mental Disorders; SCID: Structured Clinical Interview; DIGS:
Diagnostic Instrument for Genetic Studies; NS: Not speciﬁed; Vs.: versus.
* Checklist for measuring study quality developed by Downs and Black.
a Episodic OCD: at least one circumscribed symptom-free interval (six months) was present.
b Chronic OCD: if symptoms persisted for most of the course, causing signiﬁcant distress and impairment in functioning.
c Chronic BD: if all criteria for a major mood episode were met continuously for at least two years. Differences statistically signiﬁcant (p < 0.05).
1 Goes, F.S., Mccusker, M.G., Bienvenu, O.J., et al., 2012. Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical
characteristics of co-morbid panic disorder, social phobia, speciﬁc phobia and obsessive–compulsive disorder. Psychol. Med. 42(7), 1449–1459.
2 Koyuncu, A., Tukel, R., Ozyildirim, I., et al., 2010. Impact of obsessive–compulsive disorder comorbidity on the sociodemographic and clinical features of patients with
bipolar disorder. Compr. Psychiatry 51(3), 293–297.
3 Issler, C.K., Amaral, J.A., Tamada, R.S., et al., 2005. Clinical expression of obsessive–compulsive disorder in women with bipolar disorder. Revista brasileira de psiquiatria
(Sao Paulo, Brazil: 1999) 27(2), 139–142.
4 Issler, C.K., Monkul, E.S., De Mello Siqueira Amaral, J.A., et al., 2010. Bipolar disorder and comorbid obsessive–compulsive disorder is associated with higher rates of
anxiety and impulse control disorders. Acta Neuropsychiatrica 22(2), 81–86.
5 Mahasuar, R., Janardhan Reddy, Y.C., Math, S.B., 2011. Obsessive–compulsive disorder with and without bipolar disorder. Psychiatry Clin. Neurosci. 65(5), 423–433.
6 Ozdemiroglu, F., Sevincok, L., Sen, G., et al., 2015. Comorbid obsessive–compulsive disorder with bipolar disorder: A distinct form? Psychiatry Res. [Epub ahead of print].
7 Perugi, G., Akiskal, H.S., Pfanner, C. et al., 1997. The clinical impact of bipolar and unipolar affective comorbidity on obsessive–compulsive disorder. J. Affect. Disord. 46(1),
15–23.
8 Perugi, G., Akiskal, H.S., Ramacciotti, S., et al., 1999. Depressive comorbidity of panic, social phobic, and obsessive–compulsive disorders re-examined: is there a bipolar II
connection? J. Psychiatr. Res. 33(1), 53–61.
9 Perugi, G., Toni, C., Frare, F., et al., 2002. Obsessive–compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J. Clin.
Psychiatry 63(12), 1129–1134.
10 Strakowski, S.M., Sax, K.W., Mcelroy, S.L., et al., 1998. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a ﬁrst psychiatric
hospitalization. J. Clin. Psychiatry 59(9), 465–471.
11 Tukel, R., Meteris, H., Koyuncu, A., et al., 2006. The clinical impact of mood disorder comorbidity on obsessive–compulsive disorder. Eur. Arch. Psychiatry Clin. Neurosci.
256(4), 240–245.
12 Tukel, R., Oﬂaz, S.B., Ozyildirim, I., et al., 2007. Comparison of clinical characteristics in episodic and chronic obsessive–compulsive disorder. Depress. Anxiety 24(4), 251–
255.
13 Zutshi, A., Kamath, P., Reddy, Y.C., 2007. Bipolar and nonbipolar obsessive–compulsive disorder: a clinical exploration. Compr. Psychiatry 48(3), 245–251.
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profound chronic course of OCD in OCD-BD patients was
conducted in a small group of 15 women mainly with BD-I. Two
studies conducted in BD patients reported higher rates of chronic
course of BD in OCD-BD patients versus non-comorbid patients.
Most BD–-OCD subjects either had OCD conﬁned exclusively to
depressive episodes or reported worsening of OCD during
depression; in particular, one report showed that in 44% of
BD–OCD patients BD and OCD cycled together. When assessed, the
total number of depressive episodes was higher in patients with
OCD-BD comorbidity than in BD alone.
3. Limitations
The main limitation of this updated systematic review is linked
to the study design and analysis strategy of the included studies, as
documented in the quality assessment scale used. Most studies are
observational and based on retrospective assessments. Small
sample size and enrolment of subjects mainly from BD–OCD
outpatient units may limit generalizability of these results.
The use of retrospective assessment scales with low sensitivity
in discriminating true ego-dystonic obsessions from depressive
ruminations may have biased results towards an overestimation of
obsessive symptom prevalence. In addition, patients included in
the review were mainly recruited from specialized BD and OCD
outpatient units; this might have introduced selection bias and
limited the generalizability of ﬁndings to the community, where
such patients tend to be less refractory.
4. Conclusions
Results from this review support the view that the majority of
cases of comorbid BD–OCD are, in fact, BD cases. Considering
course of illness as a key diagnostic validator, especially among
patients with a primary diagnosis of BD, the majority of comorbid
OCD cases appeared to be related to mood episodes. OC symptoms
in comorbid patients appeared more often – and sometimes
exclusively – during depressive episodes, and comorbid BD and
OCD cycled together, with OC symptoms often remitting during
manic/hypomanic episodes.
Comorbid BD–OCD course of illness would explain why OCD
and BD symptoms respond to adequate mood stabilizer treatment
(Amerio et al., 2014b). Only in a minority of comorbid patients with
persistent OCD, despite improvement in mood episodes, addition
of low doses of antidepressants could be considered while strictly
monitoring emerging symptoms of mania or mixed states.
These results would conﬁrm the hypothesis of Mayer-Gross and
colleagues reported in a standard 1969 psychiatry textbook:
These people (BD–OCD patients) who, in time of health, show
no noteworthy obsessional traits, but who have phases in which
compulsive symptoms appear out of the blue and rapidly
mount up to complete incapacitation... Nevertheless theseillnesses remit and relapse in very much the same way as
cyclothymic illnesses, may show just as much regularity of
timing, and are probably to be included, from the aetiological
point of view, in the manic-depressive disorders (Mayer-Gross
et al., 1969).
Further original studies are needed to clarify BD–OCD
comorbidity. In particular, studies addressing neurobiological
substrates are essential to illuminate pathogenetic mechanisms
that underlie comorbid BD–OCD.
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